Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthma
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tofimilast | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in FEV1 compared to placebo |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in other lung function parameters, disease control and quality of life compared to placebo |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Encinitas | California | 92024 | United States | ||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Riverside |
| California |
| 92506 |
| United States |
| Pfizer Investigational Site | DeLand | Florida | 32720 | United States |
| Pfizer Investigational Site | Atlanta | Georgia | 30281 | United States |
| Pfizer Investigational Site | Normal | Illinois | 61761 | United States |
| Pfizer Investigational Site | Madisonville | Kentucky | 42431 | United States |
| Pfizer Investigational Site | North Dartmouth | Massachusetts | 02747 | United States |
| Pfizer Investigational Site | Springfield | Massachusetts | 01107 | United States |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55402 | United States |
| Pfizer Investigational Site | Skillman | New Jersey | 08558 | United States |
| Pfizer Investigational Site | Cincinnati | Ohio | 45241 | United States |
| Pfizer Investigational Site | Lincoln | Rhode Island | 02865 | United States |
| Pfizer Investigational Site | Kingsport | Tennessee | 37660 | United States |
| Pfizer Investigational Site | Nashville | Tennessee | 37203 | United States |
| Pfizer Investigational Site | Dallas | Texas | 75231 | United States |
| Pfizer Investigational Site | Madison | Wisconsin | 53792 | United States |
| Pfizer Investigational Site | Barrio Aranjuez | Provincia de San José | Costa Rica |
| Pfizer Investigational Site | San José | Provincia de San José | Costa Rica |
| Pfizer Investigational Site | Mumbai | Maharashtra | 400 014 | India |
| Pfizer Investigational Site | Chennai | Tamil Nadu | 600 034 | India |
| Pfizer Investigational Site | Vellore | Tamil Nadu | 632002 | India |
| Pfizer Investigational Site | Noida | Uttar Pradesh | 201301 | India |
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012130 | Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C517806 | tofimilast |
Not provided
Not provided
Not provided